Literature DB >> 7253541

IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.

H H Dromeyer, W Arnold, P Kryger, J O Nielsen, K H Meyer zum Büschenfelde.   

Abstract

In 75 healthy HBsAg carriers with normal liver tissue who were followed over a four years period, anti-HBc IgM was determined by ELISA. 61 HBsAg carriers (81%) were positive for anti-HBc IgM at first investigation. 54 individuals demonstrated persistence of anti-HBc IgM, 7 became anti-HBc IgM-negative within the observation period. 12 persons were persistent anti-HBc IgM of low quantities. 3 of 4 individuals with HBsAg clearance demonstrated a considerable decrease of anti-HBc IgM concentration. Although signs of liver damage or development of chronic liver diseases were not observed at the time of control biopsy the existence of anti-HBcIgM indicates that there exists also in healthy HBsAg carriers a persistent stimulation by HBcAg, inducing the production of anti-HBc IgM as a sign of permanent ongoing virus B replication. These results require a new and critical review of the "healthy" HBsAg carrier state.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7253541     DOI: 10.1007/bf02593859

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and deomnstration of circular double-stranded DNA molecule extruding directly from their cores.

Authors:  T Takahashi; S Nakagawa; T Hashimoto; K Takahashi; M Imai
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

2.  Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.

Authors:  W Szmuness; J H Hoofnagle; C E Stevens; A M Prince
Journal:  Am J Epidemiol       Date:  1976-09       Impact factor: 4.897

3.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  Association of dane particles with e antigen in the serum of asymptomatic carriers of hepatitis B surface antigen.

Authors:  K Takahashi; M Imai; F Tsuda; T Takahashi; Y Miyakawa
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

5.  Letter: Infectivity of serum containing HBsAg and antibody to e antigen.

Authors:  K R Berquist; J E Maynard; B L Murphy
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

6.  Letter: e Antigen in HBs Ag-carrier mothers.

Authors:  I L Schweitzer; V M Edwards; M Brezina
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

7.  e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.

Authors:  N El Sheikh; I L Woolf; R M Galbraith; A L Eddleston; I W Dymock; R Williams
Journal:  Br Med J       Date:  1975-11-01

8.  [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

Authors:  J Knolle; M Born; G Hess; O Klinge; W Arnold; H Bitz; K H Meyer
Journal:  Klin Wochenschr       Date:  1976-06-15

9.  Follow-up of anti-HBc titers in healthy HBsAg carriers and patients with chronic inflammatory liver diseases.

Authors:  H H Dormeyer; W Arnold; H Schönborn; G Hess; J Knolle; K H Meyer zum Büschenfelde
Journal:  Digestion       Date:  1981       Impact factor: 3.216

10.  Core antigen and circulating anti-core antibody in hepatitis B infection.

Authors:  C R Howard; A J Zuckerman
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

View more
  1 in total

1.  Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

Authors:  W H Gerlich; A Uy; F Lambrecht; R Thomssen
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.